<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0043346" disease_type="Neoplastic Process" abbrv="">Xeroderma pigmentosum</z:e> group A (<z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e>) participates in modulating recognition of DNA damage during the DNA nucleotide excision repair process </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e> A23G polymorphism has been investigated in case-control studies to evaluate the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk attributed to the variant, but the results were conflicting </plain></SENT>
<SENT sid="2" pm="."><plain>To clarify the effect of <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e> A23G polymorphism in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk, we conducted a meta-analysis that included 30 published case-control studies </plain></SENT>
<SENT sid="3" pm="."><plain>Overall, no significant association of <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e> A23G variant with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility was observed for any genetic model </plain></SENT>
<SENT sid="4" pm="."><plain>However, significant association was observed for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (GG vs. AA: OR = 1.68, 95% CI = 1.15-2.44; dominant genetic model GG + AG vs. AA: OR = 1.54, 95% CI = 1.08-1.17), for <z:hpo ids='HP_0003002'>breast cancer</z:hpo> an increased but non-significant risk was found (GG vs. AA: OR = 1.27, 95% CI = 0.98-1.66; dominant genetic model GG + AG vs. AA: OR = 1.27, 95% CI = 0.99-1.63), and for <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> an increased risk was observed in recessive model (OR = 1.19, 95% CI = 1.02-1.38), whereas for <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> a significant reduced risk was observed (GG vs. AA: OR = 0.77, 95% CI = 0.66–0.90; dominant genetic model GG + AG vs. AA: OR = 0.76, 95% CI = 0.66-0.87), it’s noting that in Asian population the inverse association was more apparent </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, in Asian population for <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> a significant decreased risk was also found in dominant genetic model (OR = 0.55; 95% CI = 0.43-0.70) and for <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> an increased risk was observed in dominant genetic model (OR = 1.51, 95% CI = 1.03-2.23) </plain></SENT>
<SENT sid="6" pm="."><plain>The meta-analysis suggested that the <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e> A23G G allele is a low-penetrant risk factor for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>